Evidence map›Paper›PMID 41492746›Full record

Observational studyZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

[Effectiveness and safety of non-surgical management for intrauterine retained products of conception: A prospective observational study].

Xingyi Gao, Jingrong Deng, Zixuan Cui, Xiangyang Zeng, Dabao Xu

Abstract readObservational StudyEnglish Abstract
In one paragraph

Observational study in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xingyi GaoDepartment of Gynecology and Obstetrics, Third Xiangya Hospital, Central South University, Changsha 410013, China. 1095593841@ qq.com.
Jingrong DengDepartment of Gynecology and Obstetrics, Third Xiangya Hospital, Central South University, Changsha 410013, China.
Zixuan CuiDepartment of Gynecology and Obstetrics, Third Xiangya Hospital, Central South University, Changsha 410013, China.
Xiangyang ZengDepartment of Gynecology and Obstetrics, Third Xiangya Hospital, Central South University, Changsha 410013, China. 441783907@qq.com.
Dabao XuDepartment of Gynecology and Obstetrics, Third Xiangya Hospital, Central South University, Changsha 410013, China. dabaoxu2022@163.com.

Funding

the Scientific Research Program of Furong Laboratory 2023SK2109
6 · The paper itself

Abstract

objectivesIntrantering retained products of conception (RPOC) are common postpartum or post-abortion complications. Although surgical management is effective, it carries risks such as endometrial injury and potential negative impacts on fertility. Retrospective studies suggest that non-surgical treatment may be safe and effective for selected patients with RPOC; however, prospective evidence remains lacking. This study aims to prospectively evaluate the effectiveness and safety of non-surgical management for RPOC.

methodsClinical data of patients diagnosed with intrauterine RPOC by ultrasound and presenting for the first time at the outpatient clinic of the Department of Gynecology and Obstetrics of the Third Xiangya Hospital, Central South University, from January 2023 to December 2024 were prospectively collected. Outcomes assessed included spontaneous expulsion of retained tissue, conversion to surgical treatment, and the incidence of heavy bleeding or infection during non-surgical management.

resultsA total of 275 patients with intrauterine RPOC were enrolled. Among them, 181 patients (65.82%) experienced spontaneous expulsion, 25 (9.09%) remained under non-surgical management, and 69 (25.09%) converted to surgical treatment. Of the 69 patients, 64 had no complications but opted for surgery due to unwillingness to continue waiting, while 5 patients underwent emergency hospitalization for heavy bleeding and subsequently converted to surgery after medical stabilization. Among the 181 patients with spontaneous expulsion, the median time to RPOC resolution was 81.0 (57.0, 106.5) days. The distribution of expulsion time was as follows: with 30 days, 3 cases (1.66%); 31-60 days, 45 cases (24.86%); 61-90 days, 59 cases (32.60%); 91-120 days, 45 cases (24.86%); ≥121 days, 29 cases (16.02%). For the 69 patients who underwent surgery, the median waiting time was 73 (53, 101) days. Time-to-surgery distribution was as follows: within 30 days of pregnancy termination, 5 cases (7.25%); 31-60 days, 14 cases (20.29%); 61-90 days, 26 cases (37.68%); 91-120 days, 12 cases (17.39%); ≥121 days, 12 cases (17.39%). During non-surgical management, 8 patients (2.91%) developed heavy bleeding; all were successfully managed with inpatient medical treatment, with marked reduction in bleeding, and none required uterine artery embolization or hysterectomy. Among these, 5 converted to surgery, while 3 chose to continue non-surgical management and subsequently expelled the retained tissue spontaneously. Four patients showed elevated C-reactive protein levels, but none exhibited clinical signs of infection. For the 64 complication-free patients who elected surgery due to personal preference, paired comparisons between their complications between their initial and preoperative evaluations showed significant reductions in β-human chorionic gonadotropin (β-hCG), uterine volume, and maximum diameter of retained tissue, as well as decreases in vascular flow grading and the proportion of enhanced myometrial vascularity (EMV) (all

conclusionsIn the absence of active bleeding or infection, non-surgical management of intrauterine RPOC is effective and relatively safe and may be considered an alternative treatment option.

Indexed as

Placenta, RetainedAdultFemaleHumansPregnancyProspective StudiesTreatment OutcomeYoung Adulteffectivenessenhanced myometrial vascularityhuman chorionic gonadotropin beta submitnon-surgical managementretained products of conceptionsafety

Identifiers

PMID41492746
PMCPMC12740736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.